Management of cutaneous side effects of EGFR inhibitors: recommendations from a German expert panel for the primary treating physician

Inhibitors of the epidermal growth factor receptor (EGFR) are increasingly used in the treatment of various entities of malignant tumors. Patients treated with EGFR inhibitors very likely develop cutaneous side effects.

Bibliographic Details

Main Authors:	Gutzmer, Ralf (Author) , Becker, Jürgen C. (Author) , Enk, Alexander (Author) , Garbe, Claus (Author) , Hauschild, Axel (Author) , Leverkus, Martin (Author) , Reimer, Georg (Author) , Treudler, Regina (Author) , Tsianakas, Athanasios (Author) , Ulrich, Claas (Author) , Wollenberg, Andreas (Author) , Homey, Bernhard (Author)
Format:	Article (Journal)
Language:	English
Published:	2011
In:	Journal der Deutschen Dermatologischen Gesellschaft Year: 2011, Volume: 9, Issue: 3, Pages: 195-202
ISSN:	1610-0387
DOI:	10.1111/j.1610-0387.2010.07561.x
Online Access:	Verlag, lizenzpflichtig, Volltext: https://doi.org/10.1111/j.1610-0387.2010.07561.x Verlag, lizenzpflichtig, Volltext: https://onlinelibrary.wiley.com/doi/10.1111/j.1610-0387.2010.07561.x
Author Notes:	Ralf Gutzmer, Jürgen C. Becker, Alexander Enk, Claus Garbe, Axel Hauschild, Martin Leverkus, Georg Reimer, Regina Treudler, Athanasios Tsianakas, Claas Ulrich, Andreas Wollenberg, Bernhard Homey